Publications by authors named "Pia Vihinen"

39Publications

High baseline Tie1 level predicts poor survival in metastatic breast cancer.

BMC Cancer 2019 Jul 24;19(1):732. Epub 2019 Jul 24.

Department of Oncology, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, P.O. Box 100, FI-33014, Tampere, Finland.

View Article and Find Full Text PDF
July 2019

Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.

Clin Breast Cancer 2019 08 4;19(4):e522-e533. Epub 2019 Apr 4.

Department of Oncology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Oncology, Tampere University Hospital, Tampere, Finland.

View Article and Find Full Text PDF
August 2019

Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.

Anticancer Res 2018 Nov;38(11):6393-6397

Department of Oncology and Radiotherapy, University of Turku and Turku University Hospital and FICAN West Cancer Centre, Turku, Finland.

View Article and Find Full Text PDF
November 2018

Selective internal radiation therapy (SIRT) as treatment for hepatic metastases of uveal melanoma: a Finnish nation-wide retrospective experience.

Acta Oncol 2018 Oct 23;57(10):1373-1380. Epub 2018 Apr 23.

a Department of Oncology , Comprehensive Cancer Centre, University of Helsinki and Helsinki University Hospital , Helsinki , Finland.

View Article and Find Full Text PDF
October 2018

One-cm Versus 2-cm Excision Margins for Patients With Intermediate Thickness Melanoma: A Matched-Pair Analysis.

Dermatol Surg 2015 Oct;41(10):1130-6

Departments of *General and Plastic Surgery, and †Oncology, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
October 2015

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Cancer Immunol Immunother 2015 Feb 16;64(2):173-80. Epub 2014 Oct 16.

Department of Oncology and Radiotherapy, Turku University Hospital, POB 52, 20521, Turku, Finland,

View Article and Find Full Text PDF
February 2015

Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.

Acta Oncol 2012 May 10;51(5):662-8. Epub 2012 Apr 10.

Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland.

View Article and Find Full Text PDF
May 2012

Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.

J Med Case Rep 2011 Jun 27;5:243. Epub 2011 Jun 27.

Department of Oncology and Radiotherapy, Turku University Hospital, PO Box 52, Fin-20521 Turku, Finland.

View Article and Find Full Text PDF
June 2011

Melanoma imaging with highly specific PET probes: ready for prime time?

J Nucl Med 2011 Jan 13;52(1):5-7. Epub 2010 Dec 13.

Department of Oncology and Radiotherapy, Turku PET Centre, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
January 2011

Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.

Acta Oncol 2009 ;48(3):460-7

Department of Surgery, Plastic and Reconstructive Surgery Unit, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
April 2009

Diagnostic and prognostic role of matrix metalloproteases in cancer.

Expert Opin Med Diagn 2008 Sep;2(9):1025-39

Turku University Hospital, Department of Oncology and Radiotherapy, POB 52, FIN-20521 Turku, Finland +358 2 313 0804 ; +358 2 313 2809 ;

View Article and Find Full Text PDF
September 2008

Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.

Melanoma Res 2008 Aug;18(4):268-73

Departments of aOncology and Radiotherapy bSurgery, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
August 2008

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Ann Surg Oncol 2007 Dec 9;14(12):3566-74. Epub 2007 Oct 9.

Department of Surgery, Turku University Hospital, P.O. Box 52, FIN-20521, Turku, Finland.

View Article and Find Full Text PDF
December 2007

Serum angiogenin levels predict treatment response in patients with stage IV melanoma.

Clin Exp Metastasis 2007 29;24(7):567-74. Epub 2007 Aug 29.

Department of Oncology and Radiotherapy, Turku University Hospital, POB 52, Turku 20521, Finland.

View Article and Find Full Text PDF
January 2008

Serum VEGF-C is associated with metastatic site in patients with malignant melanoma.

Acta Oncol 2007 ;46(5):678-84

Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
September 2007

Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme.

Pharmacoeconomics 2005 ;23(8):803-15

Department of Social Pharmacy, Center for Pharmaceutical Policy and Economics, University of Kuopio, Kuopio, Finland.

View Article and Find Full Text PDF
January 2006

Matrix metalloproteinases as therapeutic targets in cancer.

Curr Cancer Drug Targets 2005 May;5(3):203-20

Department of Oncology and Radiotherapy, Turku University Hospital, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland.

View Article and Find Full Text PDF
May 2005

Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.

Melanoma Res 2004 Feb;14(1):29-37

Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
February 2004

New prognostic factors and developing therapy of cutaneous melanoma.

Ann Med 2003 ;35(2):66-78

Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.

View Article and Find Full Text PDF
October 2003

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Int J Cancer 2002 May;99(2):157-66

Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland.

View Article and Find Full Text PDF
May 2002